BiotechTube
Analiza

Analiza

Cleveland, United States· Est.
analiza.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $7.8M

Overview

Analiza is a long-established, private contract research organization (CRO) focused exclusively on the early drug discovery phase. The company provides critical analytical services, including solubility, logD/logP, pKa, and in-vitro ADME assays, which are essential for screening and optimizing lead compounds. With nearly three decades of operation, Analiza has built a reputation for rapid turnaround, methodological expertise, and serving a diverse client base from large pharma to academic labs. Its business model is purely service-based, generating revenue from analytical testing rather than developing its own therapeutic pipeline.

DiagnosticsProteomics

Technology Platform

Suite of miniaturized, automated, gold-standard analytical assays for physicochemical property profiling (solubility, logD/logP, pKa) and in-vitro ADME screening (microsomal/plasma stability, PAMPA). Utilizes advanced instrumentation like UPLC/HPLC and LC-QTOFMS.

Funding History

2
Total raised:$7.8M
Series A$5M
Seed$2.8M

Opportunities

Growth is driven by the sustained demand for small-molecule drug discovery and the increasing outsourcing by both large pharma and capital-efficient virtual biotechs.
Expansion into biomolecule characterization services opens the growing biologics and biosimilars market.
The rise of AI-generated compound libraries creates a need for high-throughput experimental validation.

Risk Factors

Revenue dependence on a concentrated client base of large pharma firms poses concentration risk.
The company faces competition from both large, full-service CROs and other niche providers.
Its service-only model is vulnerable to technological disruption or operational failures that compromise data quality or turnaround time.

Competitive Landscape

Analiza competes in the niche segment of early-discovery analytical CROs. Key competitors include other specialized providers like Cyprotex (part of Evotec), Absorption Systems, and the early-stage service divisions of larger CROs such as Charles River Laboratories and Labcorp. Its competitive advantage lies in its deep focus, methodological expertise, fast turnaround, and reputation built over nearly three decades.

More companies in Diagnostics & Precision Medicine →More companies in United States →